Patrick M. Beardsley, Ph.D. - Publications

Affiliations: 
Pharmacology and Toxicology Virginia Commonwealth University, Richmond, VA, United States 
Area:
drug abuse, behavioral pharmacology, rat/primate self administration

72/142 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Contreras KM, Buzzi B, Vaughn J, Caillaud M, Altarifi AA, Olszewski E, Walentiny DM, Beardsley PM, Damaj MI. Characterization and validation of a spontaneous acute and protracted oxycodone withdrawal model in male and female mice. Pharmacology, Biochemistry, and Behavior. 173795. PMID 38834159 DOI: 10.1016/j.pbb.2024.173795  0.367
2024 Elder HJ, Walentiny DM, Beardsley PM. Enantiomeric contributions to methamphetamine's bidirectional effects on basal and fentanyl-depressed respiration in mice. Pharmacology, Biochemistry, and Behavior. 238: 173735. PMID 38373600 DOI: 10.1016/j.pbb.2024.173735  0.799
2023 Elder HJ, Walentiny DM, Beardsley PM. Theophylline reverses oxycodone's but not fentanyl's respiratory depression in mice while caffeine is ineffective against both opioids. Pharmacology, Biochemistry, and Behavior. 229: 173601. PMID 37414364 DOI: 10.1016/j.pbb.2023.173601  0.801
2023 Varshneya NB, Hassanien SH, Holt MC, Stevens DL, Layle NK, Bassman JR, Iula DM, Beardsley PM. Fentanyl analog structure-activity relationships demonstrate determinants of diverging potencies for antinociception and respiratory depression. Pharmacology, Biochemistry, and Behavior. 226: 173572. PMID 37236405 DOI: 10.1016/j.pbb.2023.173572  0.812
2022 Elder HJ, Varshneya NB, Walentiny DM, Beardsley PM. Amphetamines modulate fentanyl-depressed respiration in a bidirectional manner. Drug and Alcohol Dependence. 243: 109740. PMID 36608481 DOI: 10.1016/j.drugalcdep.2022.109740  0.764
2022 Varshneya NB, Walentiny DM, Stevens DL, Walker TD, Akinfiresoye LR, Beardsley PM. Structurally diverse fentanyl analogs yield differential locomotor activities in mice. Pharmacology, Biochemistry, and Behavior. 173496. PMID 36435268 DOI: 10.1016/j.pbb.2022.173496  0.786
2022 Varshneya NB, Hassanien SH, Holt MC, Stevens DL, Layle NK, Bassman JR, Iula DM, Beardsley PM. Respiratory depressant effects of fentanyl analogs are opioid receptor-mediated. Biochemical Pharmacology. 195: 114805. PMID 34673011 DOI: 10.1016/j.bcp.2021.114805  0.813
2021 Varshneya NB, Walentiny DM, Moisa LT, Walker TD, Akinfiresoye LR, Beardsley PM. Fentanyl-related substances elicit antinociception and hyperlocomotion in mice via opioid receptors. Pharmacology, Biochemistry, and Behavior. 173242. PMID 34302853 DOI: 10.1016/j.pbb.2021.173242  0.812
2021 Carper M, Contreras KM, Walentiny DM, Beardsley PM, Damaj MI. Validation and characterization of oxycodone physical dependence in C57BL/6J mice. European Journal of Pharmacology. 174111. PMID 33901461 DOI: 10.1016/j.ejphar.2021.174111  0.381
2020 Walentiny DM, Komla E, Moisa LT, Mustafa MA, Poklis JL, Akbarali HI, Beardsley PM. Methylnaltrexone crosses the blood-brain barrier and attenuates centrally-mediated behavioral effects of morphine and oxycodone in mice. Neuropharmacology. 108437. PMID 33316279 DOI: 10.1016/j.neuropharm.2020.108437  0.348
2019 Zheng Y, Obeng S, Reinecke BA, Chen C, Phansalkar PS, Walentiny DM, Gerk PM, Liu-Chen LY, Selley DE, Beardsley PM, Zhang Y. Pharmacological characterization of 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-[(3'-fluoro-4'-pyridyl)acetamido]morphinan (NFP) as a dual selective MOR/KOR ligand with potential applications in treating opioid use disorder. European Journal of Pharmacology. 172812. PMID 31743739 DOI: 10.1016/J.Ejphar.2019.172812  0.786
2019 Varshneya NB, Walentiny DM, Moisa LT, Walker TD, Akinfiresoye LR, Beardsley PM. Opioid-like antinociceptive and locomotor effects of emerging fentanyl-related substances. Neuropharmacology. PMID 30904478 DOI: 10.1016/J.Neuropharm.2019.03.023  0.784
2019 Walentiny DM, Moisa LT, Beardsley PM. Oxycodone-Like Discriminative Stimulus Effects of Fentanyl-Related Emerging Drugs of Abuse in Mice. Neuropharmacology. PMID 30735691 DOI: 10.1016/J.Neuropharm.2019.02.007  0.789
2018 Walentiny DM, Wiebelhaus JM, Beardsley PM. Nociceptin/orphanin FQ receptors modulate the discriminative stimulus effects of oxycodone in C57BL/6 mice. Drug and Alcohol Dependence. 187: 335-342. PMID 29705547 DOI: 10.1016/J.Drugalcdep.2018.02.035  0.787
2017 Bachtell RK, Jones JD, Heinzerling KG, Beardsley PM, Comer SD. Glial and neuroinflammatory targets for treating substance use disorders. Drug and Alcohol Dependence. 180: 156-170. PMID 28892721 DOI: 10.1016/J.Drugalcdep.2017.08.003  0.302
2017 Owens RA, Mustafa MA, Ignatowska-Jankowska BM, Damaj MI, Beardsley PM, Wiley JL, Niphakis MJ, Cravatt BF, Lichtman AH. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB1 receptor-mediated discriminative stimulus in mice. Neuropharmacology. PMID 28673548 DOI: 10.1016/J.Neuropharm.2017.06.032  0.534
2017 Enga RM, Rice AC, Weller P, Subler MA, Lee D, Hall CP, Windle JJ, Beardsley PM, van den Oord EJ, McClay JL. Initial characterization of behavior and ketamine response in a mouse knockout of the post-synaptic effector gene Anks1b. Neuroscience Letters. PMID 28115237 DOI: 10.1016/J.Neulet.2017.01.044  0.343
2016 Enga RM, Jackson A, Damaj MI, Beardsley PM. Oxycodone physical dependence and its oral self-administration in C57BL/6J mice. European Journal of Pharmacology. PMID 27393461 DOI: 10.1016/J.Ejphar.2016.07.006  0.436
2016 Poland RS, Hahn Y, Knapp PE, Beardsley PM, Bowers MS. Ibudilast attenuates expression of behavioral sensitization to cocaine in male and female rats. Neuropharmacology. PMID 27343385 DOI: 10.1016/J.Neuropharm.2016.06.024  0.374
2016 Owens RA, Ignatowska-Jankowska BM, Mustafa M, Beardsley PM, Wiley JL, Jali A, Selley DE, Niphakis M, Cravatt BF, Lichtman AH. Discriminative Stimulus Properties of the Endocannabinoid Catabolic Enzyme Inhibitor SA-57 in Mice. The Journal of Pharmacology and Experimental Therapeutics. PMID 27307500 DOI: 10.1124/Jpet.115.229492  0.595
2015 Wiebelhaus JM, Walentiny DM, Beardsley PM. Effects of acute and repeated administration of oxycodone and naloxone-precipitated withdrawal on Intracranial Self-Stimulation (ICSS) in rats. The Journal of Pharmacology and Experimental Therapeutics. PMID 26491062 DOI: 10.1124/Jpet.115.228940  0.794
2015 Vengeliene V, Moeller A, Meinhardt MW, Beardsley PM, Sommer WH, Spanagel R, Bespalov A. The Calpain Inhibitor A-705253 Attenuates Alcohol-Seeking and Relapse with Low Side-Effect Profile. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26216521 DOI: 10.1038/Npp.2015.225  0.31
2015 McClay JL, Vunck SA, Batman AM, Crowley JJ, Vann RE, Beardsley PM, van den Oord EJ. Neurochemical Metabolomics Reveals Disruption to Sphingolipid Metabolism Following Chronic Haloperidol Administration. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 25850894 DOI: 10.1007/S11481-015-9605-1  0.769
2015 Vengeliene V, Moeller A, Meinhardt MW, Beardsley P, Sommer WH, Spanagel R, Bespalov A. Sy09-2The Calpain Inhibitor A-705253 Attenuates Alcohol-Seeking And Relapse With Low Side-Effect Profile Alcohol and Alcoholism. 50. DOI: 10.1093/Alcalc/Agv076.35  0.301
2014 Wiley JL, Walentiny DM, Wright MJ, Beardsley PM, Burston JJ, Poklis JL, Lichtman AH, Vann RE. Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents. European Journal of Pharmacology. 737: 97-105. PMID 24858366 DOI: 10.1016/J.Ejphar.2014.05.013  0.778
2014 El-Hage N, Rodriguez M, Podhaizer EM, Zou S, Dever SM, Snider SE, Knapp PE, Beardsley PM, Hauser KF. Ibudilast (AV411), and its AV1013 analog, reduce HIV-1 replication and neuronal death induced by HIV-1 and morphine. Aids (London, England). 28: 1409-19. PMID 24732776 DOI: 10.1097/Qad.0000000000000291  0.69
2014 Beardsley PM, Hauser KF. Glial modulators as potential treatments of psychostimulant abuse. Advances in Pharmacology (San Diego, Calif.). 69: 1-69. PMID 24484974 DOI: 10.1016/B978-0-12-420118-7.00001-9  0.318
2013 Adkins DE, McClay JL, Vunck SA, Batman AM, Vann RE, Clark SL, Souza RP, Crowley JJ, Sullivan PF, van den Oord EJ, Beardsley PM. Behavioral metabolomics analysis identifies novel neurochemical signatures in methamphetamine sensitization. Genes, Brain, and Behavior. 12: 780-91. PMID 24034544 DOI: 10.1111/Gbb.12081  0.75
2013 Aberg KA, Xie LY, McClay JL, Nerella S, Vunck S, Snider S, Beardsley PM, van den Oord EJ. Testing two models describing how methylome-wide studies in blood are informative for psychiatric conditions. Epigenomics. 5: 367-77. PMID 23895651 DOI: 10.2217/Epi.13.36  0.73
2013 McClay JL, Adkins DE, Vunck SA, Batman AM, Vann RE, Clark SL, Beardsley PM, van den Oord EJ. Large-scale neurochemical metabolomics analysis identifies multiple compounds associated with methamphetamine exposure. Metabolomics : Official Journal of the Metabolomic Society. 9: 392-402. PMID 23554582 DOI: 10.1007/S11306-012-0456-Y  0.766
2013 Snider SE, Hendrick ES, Beardsley PM. Glial cell modulators attenuate methamphetamine self-administration in the rat. European Journal of Pharmacology. 701: 124-30. PMID 23375937 DOI: 10.1016/J.Ejphar.2013.01.016  0.756
2013 Shelton KL, Hendrick ES, Beardsley PM. Efficacy of buspirone for attenuating cocaine and methamphetamine reinstatement in rats. Drug and Alcohol Dependence. 129: 210-6. PMID 23374566 DOI: 10.1016/J.Drugalcdep.2013.01.003  0.317
2013 Webster K, Hillhouse T, Donahue T, Friar M, Joseph B, Beardsley P, Windle J, Stewart J, Porter J. A.10 - EFFECTS OF D-AMPHETAMINE IN VESICULAR MONOAMINE TRANSPORTER (VMAT)1 KNOCKOUT MICE SUGGEST A SCHIZOPHRENIC PHENOTYPE IN CONDITIONED AND UNCONDITIONED BEHAVIOR Behavioural Pharmacology. 24: e25. DOI: 10.1097/01.Fbp.0000434771.21238.50  0.57
2012 Beardsley PM, Shelton KL. Prime-, stress-, and cue-induced reinstatement of extinguished drug-reinforced responding in rats: cocaine as the prototypical drug of abuse. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 9.39. PMID 23093352 DOI: 10.1002/0471142301.Ns0939S61  0.353
2012 Snider SE, Vunck SA, van den Oord EJ, Adkins DE, McClay JL, Beardsley PM. The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methamphetamine locomotor activity and its sensitization in mice. European Journal of Pharmacology. 679: 75-80. PMID 22306241 DOI: 10.1016/J.Ejphar.2012.01.013  0.781
2011 McClay JL, Adkins DE, Aberg K, Bukszár J, Khachane AN, Keefe RS, Perkins DO, McEvoy JP, Stroup TS, Vann RE, Beardsley PM, Lieberman JA, Sullivan PF, van den Oord EJ. Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 616-26. PMID 21107309 DOI: 10.1038/Npp.2010.193  0.634
2010 Batman AM, Dutta AK, Reith ME, Beardsley PM. The selective dopamine uptake inhibitor, D-84, suppresses cocaine self-administration, but does not occasion cocaine-like levels of generalization. European Journal of Pharmacology. 648: 127-32. PMID 20840845 DOI: 10.1016/J.Ejphar.2010.08.051  0.348
2010 Beardsley PM, Shelton KL, Hendrick E, Johnson KW. The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapse. European Journal of Pharmacology. 637: 102-8. PMID 20399770 DOI: 10.1016/J.Ejphar.2010.04.010  0.43
2010 Beardsley PM, Pollard GT, Howard JL, Carroll FI. Effectiveness of analogs of the kappa opioid receptor antagonist (3R)-7-hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic) to reduce U50,488-induced diuresis and stress-induced cocaine reinstatement in rats. Psychopharmacology. 210: 189-98. PMID 20372878 DOI: 10.1007/S00213-010-1846-3  0.456
2009 Kharkar PS, Batman AM, Zhen J, Beardsley PM, Reith ME, Dutta AK. Synthesis and biological characterization of (3R,4R)-4-(2-(benzhydryloxy)ethyl)-1-((R)-2-hydroxy-2-phenylethyl)-piperidin-3-ol and its stereoisomers for activity toward monoamine transporters. Chemmedchem. 4: 1075-85. PMID 19449323 DOI: 10.1002/Cmdc.200900085  0.328
2009 Beardsley PM, Thomas BF, McMahon LR. Cannabinoid CB1 receptor antagonists as potential pharmacotherapies for drug abuse disorders. International Review of Psychiatry (Abingdon, England). 21: 134-42. PMID 19367507 DOI: 10.1080/09540260902782786  0.368
2008 Shelton KL, Beardsley PM. Effect of drug-paired exteroceptive stimulus presentations on methamphetamine reinstatement in rats. Pharmacology, Biochemistry, and Behavior. 90: 434-40. PMID 18456312 DOI: 10.1016/J.Pbb.2008.03.028  0.352
2006 Newman JL, Beardsley PM. Effects of memantine, haloperidol, and cocaine on primary and conditioned reinforcement associated with cocaine in rhesus monkeys. Psychopharmacology. 185: 142-9. PMID 16425059 DOI: 10.1007/S00213-005-0282-2  0.604
2006 Vann RE, Balster RL, Beardsley PM. Dose, duration, and pattern of nicotine administration as determinants of behavioral dependence in rats. Psychopharmacology. 184: 482-93. PMID 16001123 DOI: 10.1007/S00213-005-0037-0  0.674
2005 Beardsley PM, Howard JL, Shelton KL, Carroll FI. Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats. Psychopharmacology. 183: 118-26. PMID 16184376 DOI: 10.1007/S00213-005-0167-4  0.418
2005 Beardsley PM, Thomas BF. Current evidence supporting a role of cannabinoid CB1 receptor (CB1R) antagonists as potential pharmacotherapies for drug abuse disorders. Behavioural Pharmacology. 16: 275-96. PMID 16148435 DOI: 10.1097/00008877-200509000-00003  0.374
2005 Batman AM, Munzar P, Beardsley PM. Attenuation of nicotine's discriminative stimulus effects in rats and its locomotor activity effects in mice by serotonergic 5-HT2A/2C receptor agonists. Psychopharmacology. 179: 393-401. PMID 15565434 DOI: 10.1007/S00213-004-2035-Z  0.396
2004 Kolhatkar R, Cook CD, Ghorai SK, Deschamps J, Beardsley PM, Reith ME, Dutta AK. Further structurally constrained analogues of cis-(6-benzhydrylpiperidin-3-yl)benzylamine with elucidation of bioactive conformation: discovery of 1,4-diazabicyclo[3.3.1]nonane derivatives and evaluation of their biological properties for the monoamine transporters. Journal of Medicinal Chemistry. 47: 5101-13. PMID 15456254 DOI: 10.1021/Jm049796T  0.326
2004 Beardsley PM, Aceto MD, Cook CD, Bowman ER, Newman JL, Harris LS. Discriminative stimulus, reinforcing, physical dependence, and antinociceptive effects of oxycodone in mice, rats, and rhesus monkeys. Experimental and Clinical Psychopharmacology. 12: 163-72. PMID 15301633 DOI: 10.1037/1064-1297.12.3.163  0.649
2004 Cook CD, Beardsley PM. Modulation of the discriminative stimulus effects of mu opioid agonists in rats: II. Effects of dopamine D2/3 agonists. Behavioural Pharmacology. 15: 75-83. PMID 15075629 DOI: 10.1097/00008877-200402000-00009  0.341
2004 Cook CD, Beardsley PM. Modulation of the discriminative stimulus effects of mu opioid agonists in rats: I. Effects of dopamine D2/3 antagonists. Behavioural Pharmacology. 15: 65-74. PMID 15075628 DOI: 10.1097/00008877-200402000-00008  0.346
2004 Cook CD, Newman JL, Winfree JC, Beardsley PM. Modulation of the locomotor activating effects of the noncompetitive NMDA receptor antagonist MK801 by dopamine D2/3 receptor agonists in mice. Pharmacology, Biochemistry, and Behavior. 77: 309-18. PMID 14751459 DOI: 10.1016/J.Pbb.2003.11.002  0.633
2003 Cook CD, Beardsley PM. The modulatory actions of dopamine D2/3 agonists and antagonists on the locomotor-activating effects of morphine and caffeine in mice. Pharmacology, Biochemistry, and Behavior. 75: 363-71. PMID 12873628 DOI: 10.1016/S0091-3057(03)00090-X  0.473
2003 Kozikowski AP, Johnson KM, Deschaux O, Bandyopadhyay BC, Araldi GL, Carmona G, Munzar P, Smith MP, Balster RL, Beardsley PM, Tella SR. Mixed cocaine agonist/antagonist properties of (+)-methyl 4beta-(4-chlorophenyl)-1-methylpiperidine-3alpha-carboxylate, a piperidine-based analog of cocaine. The Journal of Pharmacology and Experimental Therapeutics. 305: 143-50. PMID 12649362 DOI: 10.1124/Jpet.102.046318  0.329
2003 Ghorai SK, Cook C, Davis M, Venkataraman SK, George C, Beardsley PM, Reith ME, Dutta AK. High affinity hydroxypiperidine analogues of 4-(2-benzhydryloxyethyl)-1-(4-fluorobenzyl)piperidine for the dopamine transporter: stereospecific interactions in vitro and in vivo. Journal of Medicinal Chemistry. 46: 1220-8. PMID 12646032 DOI: 10.1021/Jm020275K  0.335
2002 Beardsley PM, Ratti E, Balster RL, Willetts J, Trist D. The selective glycine antagonist gavestinel lacks phencyclidine-like behavioral effects. Behavioural Pharmacology. 13: 583-92. PMID 12409996  0.319
2002 Newman JL, Vann RE, May EL, Beardsley PM. Heroin discriminative stimulus effects of methadone, LAAM and other isomers of acetylmethadol in rats. Psychopharmacology. 164: 108-14. PMID 12373424 DOI: 10.1007/S00213-002-1198-8  0.738
2002 Cook CD, Carroll FI, Beardsley PM. RTI 113, a 3-phenyltropane analog, produces long-lasting cocaine-like discriminative stimulus effects in rats and squirrel monkeys. European Journal of Pharmacology. 442: 93-8. PMID 12020686 DOI: 10.1016/S0014-2999(02)01501-7  0.343
2002 Cook CD, Aceto MD, Coop A, Beardsley PM. Effects of the putative antagonist NCS382 on the behavioral pharmacological actions of gammahydroxybutyrate in mice. Psychopharmacology. 160: 99-106. PMID 11862379 DOI: 10.1007/S00213-001-0951-8  0.436
2002 Dutta AK, Davis MC, Fei XS, Beardsley PM, Cook CD, Reith ME. Expansion of structure-activity studies of piperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine (GBR 12935) compounds by altering substitutions in the N-benzyl moiety and behavioral pharmacology of selected molecules. Journal of Medicinal Chemistry. 45: 654-62. PMID 11806716 DOI: 10.1021/Jm010316X  0.342
2001 Cook CD, Carroll IF, Beardsley PM. Cocaine-like discriminative stimulus effects of novel cocaine and 3-phenyltropane analogs in the rat. Psychopharmacology. 159: 58-63. PMID 11797070 DOI: 10.1007/S002130100891  0.313
2001 Willmore CB, Bespalov AY, Beardsley PM. Competitive and noncompetitive NMDA antagonist effects in rats trained to discriminate lever-press counts. Pharmacology, Biochemistry, and Behavior. 69: 493-502. PMID 11509209 DOI: 10.1016/S0091-3057(01)00568-8  0.373
2001 Bespalov AY, Zvartau EE, Beardsley PM. Opioid-NMDA receptor interactions may clarify conditioned (associative) components of opioid analgesic tolerance. Neuroscience and Biobehavioral Reviews. 25: 343-53. PMID 11445139 DOI: 10.1016/S0149-7634(01)00018-5  0.353
2001 Dutta AK, Fei XS, Beardsley PM, Newman JL, Reith ME. Structure-activity relationship studies of 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives and their N-analogues: evaluation of O-and N-analogues and their binding to monoamine transporters. Journal of Medicinal Chemistry. 44: 937-48. PMID 11300876 DOI: 10.1021/Jm000311K  0.581
2000 Bespalov AY, Dravolina OA, Zvartau EE, Beardsley PM, Balster RL. Effects of NMDA receptor antagonists on cocaine-conditioned motor activity in rats. European Journal of Pharmacology. 390: 303-11. PMID 10708738 DOI: 10.1016/S0014-2999(99)00927-9  0.423
1999 Bespalov AY, Balster RL, Beardsley PM. N-Methyl-D-aspartate receptor antagonists and the development of tolerance to the discriminative stimulus effects of morphine in rats. The Journal of Pharmacology and Experimental Therapeutics. 290: 20-7. PMID 10381755  0.379
1999 Bespalov AY, Tokarz ME, Bowen SE, Balster RL, Beardsley PM. Effects of test conditions on the outcome of place conditioning with morphine and naltrexone in mice. Psychopharmacology. 141: 118-22. PMID 9952035 DOI: 10.1007/S002130050815  0.467
1998 Bespalov AY, Beardsley PM, Balster RL. Interactions between N-methyl-D-aspartate receptor antagonists and the discriminative stimulus effects of morphine in rats. Pharmacology, Biochemistry, and Behavior. 60: 507-17. PMID 9632234 DOI: 10.1016/S0091-3057(98)00006-9  0.381
1996 Beardsley PM, Balster RL, Harris LS. Evaluation of the discriminative stimulus and reinforcing effects of gammahydroxybutyrate (GHB). Psychopharmacology. 127: 315-22. PMID 8923566 DOI: 10.1007/s002130050092  0.305
1992 Chandrakumar NS, Stapelfeld A, Beardsley PM, Lopez OT, Drury B, Anthony E, Savage MA, Williamson LN, Reichman M. Analogs of the delta opioid receptor selective cyclic peptide [2-D-penicillamine,5-D-penicillamine]-enkephalin: 2',6'-dimethyltyrosine and Gly3-Phe4 amide bond isostere substitutions. Journal of Medicinal Chemistry. 35: 2928-38. PMID 1323677  0.398
1989 Knisely JS, Beardsley PM, Aceto MD, Balster RL, Harris LS. Assessment of the abuse potential of acetorphan, an enkephalinase inhibitor. Drug and Alcohol Dependence. 23: 143-51. PMID 2702924 DOI: 10.1016/0376-8716(89)90020-3  0.369
1987 Beardsley PM, Scimeca JA, Martin BR. Studies on the agonistic activity of delta 9-11-tetrahydrocannabinol in mice, dogs and rhesus monkeys and its interactions with delta 9-tetrahydrocannabinol. The Journal of Pharmacology and Experimental Therapeutics. 241: 521-6. PMID 3033218  0.32
Low-probability matches (unlikely to be authored by this person)
2010 Thomas BF, Beardsley PM, Seltzman HH. Current considerations for development of cannabinoid receptor 1 antagonists (Drug Development Research (2009) 70, 8 (525-526) DOI: 10.1002/ddr.20332) Drug Development Research. 71: 159. DOI: 10.1002/Ddr.20361  0.3
2002 Willmore CB, Bespalov AY, Beardsley PM. Site-selective N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonists produce distinct effects in rats performing complex discriminations. Neurobiology of Learning and Memory. 78: 347-64. PMID 12431422 DOI: 10.1006/Nlme.2002.4077  0.299
2000 Beardsley PM, Martin BR. Effects of the cannabinoid CB(1) receptor antagonist, SR141716A, after Delta(9)-tetrahydrocannabinol withdrawal. European Journal of Pharmacology. 387: 47-53. PMID 10633159 DOI: 10.1016/S0014-2999(99)00792-X  0.295
1987 Beardsley PM, Balster RL. Behavioral dependence upon phencyclidine and ketamine in the rat. The Journal of Pharmacology and Experimental Therapeutics. 242: 203-11. PMID 3612525  0.293
2006 Vargas-Irwin C, van den Oord EJ, Beardsley PM, Robles JR. A method for analyzing strain differences in acquisition of IV cocaine self-administration in mice. Behavior Genetics. 36: 525-35. PMID 16586151 DOI: 10.1007/S10519-006-9068-5  0.292
2018 Beardsley PM, Zhang Y. Synthetic Opioids. Handbook of Experimental Pharmacology. PMID 30242482 DOI: 10.1007/164_2018_149  0.29
2015 Owens R, Beardsley P, cravatt B, Lichtman A. Dual blockade of endocannabinoid hydrolyzing enzymes reveal a CB 1 receptor-mediated interoceptive stimulus Drug and Alcohol Dependence. 156: e168. DOI: 10.1016/J.Drugalcdep.2015.07.456  0.288
2013 Uguen M, Perrin D, Belliard S, Ligneau X, Beardsley PM, Lecomte JM, Schwartz JC. Preclinical evaluation of the abuse potential of Pitolisant, a histamine H₃ receptor inverse agonist/antagonist compared with Modafinil. British Journal of Pharmacology. 169: 632-44. PMID 23472741 DOI: 10.1111/bph.12149  0.287
1992 Beardsley PM, Anthony EW, Lopez OT. Phencyclidine established as a discriminative stimulus using ethanol as a reinforcer. Behavioural Pharmacology. 3: 497-505. PMID 11224152  0.284
1988 Beardsley PM, Balster RL. Evaluation of antagonists of the discriminative stimulus and response rate effects of phencyclidine. The Journal of Pharmacology and Experimental Therapeutics. 244: 34-40. PMID 3336008  0.282
2019 Younis RM, Taylor RM, Beardsley PM, McClay JL. The gene and its associated phenotypes: focus on CNS drug response. Pharmacogenomics. 20: 669-684. PMID 31250731 DOI: 10.2217/Pgs-2019-0015  0.281
2006 Cook CD, Biddlestone L, Coop A, Beardsley PM. Effects of combining ethanol (EtOH) with gamma-hydroxybutyrate (GHB) on the discriminative stimulus, locomotor, and motor-impairing functions of GHB in mice. Psychopharmacology. 185: 112-22. PMID 16453156 DOI: 10.1007/S00213-005-0276-0  0.274
2015 Fitting S, Stevens DL, Khan FA, Scoggins KL, Enga RM, Beardsley PM, Knapp PE, Dewey WL, Hauser KF. Morphine tolerance and physical dependence are altered in conditional HIV-1 Tat transgenic mice. The Journal of Pharmacology and Experimental Therapeutics. PMID 26542403 DOI: 10.1124/Jpet.115.226407  0.272
1997 Beardsley PM, Harris LS. Evaluation of the discriminative stimulus and reinforcing effects of dihydroetorphine. Drug and Alcohol Dependence. 48: 77-84. PMID 9363406 DOI: 10.1016/S0376-8716(97)00112-9  0.271
1986 Beardsley PM, Balster RL, Harris LS. Dependence on tetrahydrocannabinol in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 239: 311-9. PMID 3021952  0.268
1990 Beardsley PM, Hayes BA, Balster RL. The self-administration of MK-801 can depend upon drug-reinforcement history, and its discriminative stimulus properties are phencyclidine-like in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 252: 953-9. PMID 2181113  0.265
1998 Cook CD, Carroll FI, Beardsley PM. Separation of the locomotor stimulant and discriminative stimulus effects of cocaine by its C-2 phenyl ester analog, RTI-15. Drug and Alcohol Dependence. 50: 123-8. PMID 9649963 DOI: 10.1016/S0376-8716(98)00004-0  0.263
2010 Brunzell DH, Boschen KE, Hendrick ES, Beardsley PM, McIntosh JM. Alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors in the nucleus accumbens shell regulate progressive ratio responding maintained by nicotine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 665-73. PMID 19890263 DOI: 10.1038/Npp.2009.171  0.263
2001 Beardsley PM, Sokoloff P, Balster RL, Schwartz JC. The D3R partial agonist, BP 897, attenuates the discriminative stimulus effects of cocaine and D-amphetamine and is not self-administered. Behavioural Pharmacology. 12: 1-11. PMID 11270507  0.26
1989 Knisely JS, Beardsley PM, Aceto MD, Balster RL, Harris LS. Discriminative stimulus reinforcing and physical dependence properties of acetorphan Pharmacology Biochemistry and Behavior. 32: 1087. DOI: 10.1016/0091-3057(89)90125-1  0.259
2002 Beardsley PM, Dance ME, Balster RL, Munzar P. Evaluation of the reinforcing effects of the cannabinoid CB1 receptor antagonist, SR141716, in rhesus monkeys. European Journal of Pharmacology. 435: 209-16. PMID 11821028 DOI: 10.1016/S0014-2999(01)01597-7  0.258
2025 Elder HJ, Walentiny DM, Beardsley PM. Monoamine receptors targeted by methamphetamine differentially modulate basal and fentanyl-depressed respiration in mice. Pharmacology, Biochemistry, and Behavior. 251: 174004. PMID 40158702 DOI: 10.1016/j.pbb.2025.174004  0.257
2000 Bespalov AY, Zvartau EE, Balster RL, Beardsley PM. Effects of N-methyl-D-aspartate receptor antagonists on reinstatement of cocaine-seeking behavior by priming injections of cocaine or exposures to cocaine-associated cues in rats. Behavioural Pharmacology. 11: 37-44. PMID 10821207  0.243
1987 Martin BR, Compton DR, Little PJ, Martin TJ, Beardsley PM. Pharmacological evaluation of agonistic and antagonistic activity of cannabinoids. Nida Research Monograph. 79: 108-22. PMID 2830532  0.232
2021 Synan C, Bowen C, Heal DJ, Froger-Colléaux C, Beardsley PM, Dedic N, Hopkins SC, Campbell U, Koblan KS. Ulotaront, a novel TAAR1 agonist with 5-HT1A agonist activity, lacks abuse liability and attenuates cocaine cue-induced relapse in rats. Drug and Alcohol Dependence. 231: 109261. PMID 35033729 DOI: 10.1016/j.drugalcdep.2021.109261  0.228
1993 Beardsley PM, Balster RL. The effects of delay of reinforcement and dose on the self-administration of cocaine and procaine in rhesus monkeys. Drug and Alcohol Dependence. 34: 37-43. PMID 8174501 DOI: 10.1016/0376-8716(93)90044-Q  0.227
1994 Beardsley PM, Lopez OT, Gullikson G, Flynn D. Serotonin 5-HT3 antagonists fail to affect ethanol self-administration of rats. Alcohol (Fayetteville, N.Y.). 11: 389-95. PMID 7818797 DOI: 10.1016/0741-8329(94)90023-X  0.222
1987 Beardsley PM, Balster RL. Self-administration of minaprine in rhesus monkeys. Drug and Alcohol Dependence. 19: 121-9. PMID 3582164 DOI: 10.1016/0376-8716(87)90050-0  0.209
1993 Nevins ME, Nash SA, Beardsley PM. Quantitative grip strength assessment as a means of evaluating muscle relaxation in mice. Psychopharmacology. 110: 92-6. PMID 7870904 DOI: 10.1007/BF02246955  0.209
1986 Beardsley PM, Balster RL, Harris LS. Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys. Drug and Alcohol Dependence. 18: 149-57. PMID 2877842 DOI: 10.1016/0376-8716(86)90047-5  0.202
2021 Vohra HZ, Saunders JM, Jaster AM, de la Fuente Revenga M, Jimenez J, Fernández-Teruel A, Wolstenholme JT, Beardsley PM, González-Maeso J. Sex-specific effects of psychedelics on prepulse inhibition of startle in 129S6/SvEv mice. Psychopharmacology. PMID 34345931 DOI: 10.1007/s00213-021-05913-9  0.194
1998 Beardsley PM, Balster RL. THE GLYCINE ANTAGONIST, GV150526, DOES NOT HAVE PCP-LIKE DISCRIMINATIVE STIMULUS EFFECTS AND IS NOT SELF-ADMINISTERED Behavioural Pharmacology. 9: S14. DOI: 10.1097/00008877-199808000-00011  0.188
1984 Beardsley PM, Balster RL, Harris LS. Behavioral dependence of Rhesus monkeys on intravenously-administered delta 9-tetrahydrocannabinol Federation Proceedings. 43: no. 3905.  0.185
1992 Beardsley PM, Balster RL. The intravenous self-administration of antihistamines by rhesus monkeys. Drug and Alcohol Dependence. 30: 117-26. PMID 1353017 DOI: 10.1016/0376-8716(92)90016-6  0.181
1987 Beardsley PM, Balster RL, Salay JM. Separation of the response rate and discriminative stimulus effects of phencyclidine: training dose as a factor in phencyclidine-saline discrimination. The Journal of Pharmacology and Experimental Therapeutics. 241: 159-65. PMID 3572780  0.178
1999 Zvartau E, Bespalov A, Dravolina O, Beardsley P, Balster R. Modulation of drug-conditioned responses by NMDA receptor antagonists European Neuropsychopharmacology. 9: 159-160. DOI: 10.1016/S0924-977X(99)80041-8  0.174
2021 de la Fuente Revenga M, Zhu B, Guevara CA, Naler LB, Saunders JM, Zhou Z, Toneatti R, Sierra S, Wolstenholme JT, Beardsley PM, Huntley GW, Lu C, González-Maeso J. Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice. Cell Reports. 37: 109836. PMID 34686347 DOI: 10.1016/j.celrep.2021.109836  0.17
1995 Tessari M, Valerio E, Chiamulera C, Beardsley PM. Nicotine reinforcement in rats with histories of cocaine self-administration. Psychopharmacology. 121: 282-3. PMID 8545535 DOI: 10.1007/BF02245640  0.166
2004 Shelton KL, Hendrick E, Beardsley PM. Interaction of noncontingent cocaine and contingent drug-paired stimuli on cocaine reinstatement. European Journal of Pharmacology. 497: 35-40. PMID 15302593 DOI: 10.1016/j.ejphar.2004.06.014  0.163
1984 Beardsley PM, Balster RL, Harris LS. Behavioral dependence in rhesus monkeys following chronic THC administration. Nida Research Monograph. 55: 111-7. PMID 6100502  0.156
1995 Bespalov A, Zvartau E, Beardsley P. Kynurenic acid attenuates rewarding potential but fails to alter discriminative stimulus properties of opiates in rats Pharmacological Research. 31: 113. DOI: 10.1016/1043-6618(95)86713-9  0.152
2009 Beardsley PM. Evaluation of taranabant (MK-0364) for its self-administration in rhesus monkeys and for its discriminative stimulus effects in rats Drug Development Research. 70: 577-584. DOI: 10.1002/ddr.20336  0.152
1999 Beardsley PM. IS THERE A ROLE FOR DOPAMINE D3 RECEPTOR AGENTS IN DRUG ABUSE? Behavioural Pharmacology. 10: S7. DOI: 10.1097/00008877-199908001-00016  0.148
2022 Saunders JM, Muguruza C, Sierra S, Moreno JL, Callado LF, Meana JJ, Beardsley PM, González-Maeso J. Glucocorticoid receptor dysregulation underlies 5-HTR-dependent synaptic and behavioral deficits in a mouse neurodevelopmental disorder model. The Journal of Biological Chemistry. 102481. PMID 36100039 DOI: 10.1016/j.jbc.2022.102481  0.138
1982 Uren JR, Hargis BJ, Beardsley P. Immunological and pharmacological characterization of poly-DL-alanyl-modified Erwinia carotovora L-asparaginase Cancer Research. 42: 4068-4071. PMID 7105004  0.132
1993 Beardsley PM, Lemaire GA, Meisch RA. Persistence of ethanol self-administration as a function of interreinforcer interval and concentration. Drug and Alcohol Dependence. 34: 71-81. PMID 8174504 DOI: 10.1016/0376-8716(93)90048-U  0.129
1988 Balster R, Willetts J, Beardsley P, Hayes B, Rice A. Excitatory amino acid neurotransmission and the behavioral pharmacology of phencyclidine-like drugs Nida Research Monograph Series. 49.  0.122
1983 Beardsley PM, Lemaire GA, Meisch RA. Effects of minimum-interreinforcer interval on ethanol-maintained performance of rats. Pharmacology, Biochemistry, and Behavior. 19: 843-7. PMID 6647519 DOI: 10.1016/0091-3057(83)90091-6  0.121
1981 Beardsley PM, Meisch RA. A precision drinking device for rats tested with water, etonitazene, and ethanol. Pharmacology, Biochemistry, and Behavior. 14: 871-6. PMID 6114498 DOI: 10.1016/0091-3057(81)90376-2  0.121
1993 Chandrakumar NS, Carron CP, Meyer DM, Beardsley PM, Nash SA, Tam LL, Rafferty M. Phenylphosphonate monoester analogs of cocaine. Potential haptens for the generation of catalytic antibodies Bioorganic and Medicinal Chemistry Letters. 3: 309-312. DOI: 10.1016/S0960-894X(01)80899-4  0.11
1975 Meisch RA, Beardsley P. Ethanol as a reinforcer for rats: effects of concurrent access to water and alternate positions of water and ethanol. Psychopharmacologia. 43: 19-23. PMID 1161991 DOI: 10.1007/BF00437609  0.1
1980 Kufe DW, Beardsley P, Karp D, Parker L, Rosowsky A, Canellos G, Frei IIIrd E. High-dose thymidine infusions in patients with leukemia and lymphoma Blood. 55: 580-589. PMID 6965595  0.089
1989 Woolverton WL, Ator NA, Beardsley PM, Carroll ME. Effects of environmental conditions on the psychological well-being of primates: a review of the literature. Life Sciences. 44: 901-17. PMID 2648097 DOI: 10.1016/0024-3205(89)90489-X  0.088
1978 Beardsley PM, Lemaire GA, Meisch RA. Ethanol-reinforced behavior of rats with concurrent access to food and water. Psychopharmacology. 59: 7-11. PMID 100816 DOI: 10.1007/BF00428023  0.072
2005 Beardsley PM, Barker WR. Patterns of evolution in Australian Mimulus and related genera (Phrymaceae-Scrophulariaceae): A molecular phylogeny using chloroplast and nuclear sequence data Australian Systematic Botany. 18: 61-73. DOI: 10.1071/Sb04034  0.065
2015 Fishman L, Beardsley PM, Stathos A, Williams CF, Hill JP. The genetic architecture of traits associated with the evolution of self-pollination in Mimulus. The New Phytologist. 205: 907-17. PMID 25306861 DOI: 10.1111/Nph.13091  0.052
2006 Tank DC, Beardsley PM, Kelchner SA, Olmstead RG. Review of the systematics of Scrophulariaceae s.l. and their current disposition Australian Systematic Botany. 19: 289-307. DOI: 10.1071/Sb05009  0.048
2003 Kelso S, Bower NW, Heckmann KE, Beardsley PM, Greve DG. Geobotany of the Niobrara chalk barrens in Colorado: A study of edaphic endemism Western North American Naturalist. 63: 299-313.  0.048
2003 Beardsley PM, Yen A, Olmstead RG. AFLP phylogeny of Mimulus section Erythranthe and the evolution of hummingbird pollination. Evolution; International Journal of Organic Evolution. 57: 1397-410. PMID 12894947 DOI: 10.1111/J.0014-3820.2003.Tb00347.X  0.047
2004 Beardsley PM, Schoenig SE, Whittall JB, Olmstead RG. Patterns of evolution in western North American Mimulus (Phrymaceae). American Journal of Botany. 91: 474-89. PMID 21653403 DOI: 10.3732/Ajb.91.3.474  0.041
2006 Nie ZL, Sun H, Beardsley PM, Olmstead RG, Wen J. Evolution of biogeographic disjunction between eastern Asia and eastern North America in Phryma (Phrymaceae). American Journal of Botany. 93: 1343-56. PMID 21642199 DOI: 10.3732/Ajb.93.9.1343  0.034
2013 Fishman L, Stathos A, Beardsley PM, Williams CF, Hill JP. Chromosomal rearrangements and the genetics of reproductive barriers in mimulus (monkey flowers). Evolution; International Journal of Organic Evolution. 67: 2547-60. PMID 24033166 DOI: 10.1111/Evo.12154  0.033
2012 Beardsley PM, Bloom MV, Wise SB. Challenges and Opportunities for Teaching and Designing Effective K-12 Evolution Curricula: Fostering Change in Evolutionary Conceptions and in Epistemic Practices Evolution Challenges: Integrating Research and Practice in Teaching and Learning About Evolution. DOI: 10.1093/acprof:oso/9780199730421.003.0013  0.033
1982 Beardsley P, Klaus M. Methylation of arabinosyl cytosine (araC) residues in DNA Pediatric Research. 16: No. 720.  0.031
2004 Beardsley PM. Middle school student learning in evolution: Are current standards achievable? American Biology Teacher. 66: 604-612. DOI: 10.1662/0002-7685(2004)066[0604:Msslie]2.0.Co;2  0.026
1983 Fram R, Major P, Egan E, Beardsley P, Rosenthal D, Kufe D. A phase I-II study of combination therapy with thymidine and cytosine arabinoside. Cancer Chemotherapy and Pharmacology. 11: 43-7. PMID 6883625 DOI: 10.1007/BF00257416  0.02
2002 Beardsley PM, Olmstead RG. Redefining Phrymaceae: the placement of Mimulus, tribe Mimuleae, and Phryma. American Journal of Botany. 89: 1093-102. PMID 21665709 DOI: 10.3732/Ajb.89.7.1093  0.018
2006 Whittall JB, Carlson ML, Beardsley PM, Meinke RJ, Liston A. The Mimulus moschatus alliance (Phrymaceae): Molecular and morphological phylogenetics and their conservation implications Systematic Botany. 31: 380-397. DOI: 10.1600/036364406777585810  0.017
2009 Kelso S, Beardsley PM, Weitemier K. Phylogeny and biogeography of Primula sect. Parryi (Primulaceae) International Journal of Plant Sciences. 170: 93-106. DOI: 10.1086/593041  0.012
2012 Wei CA, Beardsley PM, Labov JB. Evolution education across the life sciences: making biology education make sense. Cbe Life Sciences Education. 11: 10-6. PMID 22383612 DOI: 10.1187/Cbe.11-12-0111  0.011
Hide low-probability matches.